Immunovant
(NASDAQ:IMVT)
$37.66
-0.70[-1.82%]
At close: Feb 28
$37.66
0[0.00%]
After Hours: 4:00PM EDT

GET A REPORT ON IMVT SENT RIGHT TO YOUR INBOX

Immunovant Stock (NASDAQ:IMVT), Earnings Estimates, EPS, and Revenue

Immunovant reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 12
EPS
$-0.360
Quarterly Revenue
$0K
Annual Revenue
(as of Dec 31)

Analyze the earnings history of Immunovant using advanced sorting and filters.

Date
time
ticker
Quarter
Prior EPS
Est EPS
Actual EPS
EPS Surprise
Prior Rev
Est Rev
Actual Rev
Rev Surprise
Get Alert
05/20/2024AMIMVTQ4-$0.46$0.00Get Alert
02/12/2024AMIMVTQ3-$0.49-$0.43-$0.3616.28%$0.00$0.00Get Alert
11/09/2023AMIMVTQ2-$0.41-$0.48-$0.456.25%$0.00$0.00Get Alert
08/10/2023AMIMVTQ1-$0.35-$0.45-$0.57-26.67%$0.00$0.00Get Alert
05/22/2023AMIMVTQ4-$0.41-$0.43-$0.46-6.98%$0.00$0.00Get Alert
02/03/2023AMIMVTQ3-$0.36-$0.39-$0.49-25.64%$0.00$0.00Get Alert
11/04/2022AMIMVTQ2-$0.35-$0.39-$0.41-5.13%$0.00$0.00Get Alert
08/05/2022AMIMVTQ1-$0.31-$0.40-$0.3512.50%$0.00$0.00Get Alert
06/08/2022AMIMVTQ4-$0.29-$0.38-$0.41-7.89%$0.00$0.00Get Alert
02/04/2022AMIMVTQ3-$0.32-$0.33-$0.36-9.09%$0.00$0.00Get Alert
11/05/2021AMIMVTQ2-$0.25-$0.30-$0.35-16.67%$0.00$0.00Get Alert
08/09/2021AMIMVTQ1-$0.38-$0.30-$0.31-3.33%$0.00$0.00Get Alert
06/01/2021AMIMVTQ4-$0.38-$0.32-$0.299.38%$0.00$0.00Get Alert
02/16/2021AMIMVTQ3-$0.28-$0.32$0.00Get Alert
11/12/2020AMIMVTQ2-$0.38-$0.34-$0.2526.47%$0.00$0.00Get Alert
08/12/2020AMIMVTQ1-$0.38$0.00Get Alert
06/29/2020AMIMVTQ4-$0.38$0.00Get Alert

FAQ

Q

When is Immunovant (NASDAQ:IMVT) reporting earnings?

A

Immunovant (IMVT) is scheduled to report earnings on May 20, 2024. The last reported earnings were for reported on February 12, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for Immunovant (NASDAQ:IMVT)?

A

The Actual EPS was $-0.36, which beat the estimate of $-0.43.

Q

What were Immunovant’s (NASDAQ:IMVT) revenues?

A

The Actual Revenue was $0K, which hit the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch